{"DataElement":{"publicId":"6384249","version":"1","preferredName":"Index And Measurable New Lesion Sum Multiplicative Product Percentage Value","preferredDefinition":"The percent change in the sum of the products of the two largest perpendicular diameters (SPD) of all index lesions (five lesions per organ, up to 10 visceral lesions and five cutaneous index lesions) is calculated.","longName":"IDX_NEW_LES_PROD_PRCT_CHG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6384245","version":"1","preferredName":"Index And Measurable New Lesion Sum Multiplicative Product","preferredDefinition":"The largest tumor lesion targeted by therapy._Capable of being measured._The identification of a lesion which has not been previously seen or characterized._The final aggregate amount._A quantity obtained by multiplication.","longName":"6384242v1.0:6384243v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6384242","version":"1","preferredName":"Index Lesion Measurable New Lesion Identification","preferredDefinition":"The largest tumor lesion targeted by therapy.:Capable of being measured.:The identification of a lesion which has not been previously seen or characterized.","longName":"C110961:C37894:C94522","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Index Lesion","conceptCode":"C110961","definition":"The most clinically significant tumor lesion targeted by therapy. The lesion is typically the largest or highest graded of the tumor foci detected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"New Lesion Identification","conceptCode":"C94522","definition":"The identification of a lesion which has not been previously seen or characterized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72C91F6C-ACAA-340D-E053-F662850AB02E","latestVersionIndicator":"Yes","beginDate":"2018-08-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-06","modifiedBy":"ONEDATA","dateModified":"2018-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6384243","version":"1","preferredName":"Sum Multiplicative Product","preferredDefinition":"The final aggregate amount.:A quantity obtained by multiplication.","longName":"C25697:C40352","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sum","conceptCode":"C25697","definition":"The final aggregate amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Multiplicative Product","conceptCode":"C40352","definition":"A quantity obtained by multiplication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"72C91F6C-ACBB-340D-E053-F662850AB02E","latestVersionIndicator":"Yes","beginDate":"2018-08-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-06","modifiedBy":"ONEDATA","dateModified":"2018-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"72C91F6C-ACCC-340D-E053-F662850AB02E","latestVersionIndicator":"Yes","beginDate":"2018-08-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-06","modifiedBy":"KNABLEJ","dateModified":"2018-10-07","changeDescription":"10/7/18 jk Released per Fall 2018 Content Team review.  8/6/18 jk Created for RECIST FG based on irRC Paper.pdf; page 3 - sec Immune-related response criteria.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2903088","version":"1","preferredName":"Percentage Value","preferredDefinition":"A numerical quantity measured or assigned or computed that is a fraction or ratio with 100 understood as the denominator.","longName":"PER_VAL","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"%","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PEARL CRF:Practitioners Engaged in Applied Research and Learning Network Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6CB91576-373C-243B-E040-BB89AD43311A","latestVersionIndicator":"Yes","beginDate":"2009-06-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-19","modifiedBy":"COOPERM","dateModified":"2019-04-17","changeDescription":"10/23/18 jk chg reg status to Standard as part of RECIST FG content; reused by 30 CDEs and multiple SOs. 10-19-2018 TMT received permission from BC to transfer ownership from NIDCR to NCI Standards.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6160006","version":"1","longName":"irRC","context":"NCI Standards"}]}],"AlternateNames":[{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"irRC tumor burden % change","type":"Preferred Question Text","description":"irRC tumor burden % change","url":null,"context":"NCI Standards"},{"name":"irRC","type":"Alternate Question Text","description":"irRC tumor burden % change","url":null,"context":"NCI Standards"}],"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"72C993C1-AF75-33D8-E053-F662850A7231","latestVersionIndicator":"Yes","beginDate":"2018-08-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-08-06","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeDescription":"10/7/18 jk Released per Fall 2018 Content Team review  8/6/18 jk created for RECIST FG irRC criteria CDE set.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}